Organogenesis Holding (ORGO) Reports In-Line Q4 EPS

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $115.5 million versus the consensus estimate of $122.05 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Bright Horizons (BFAM) PT Lowered to $87 at UBS Ahead of Q2 Results
• Freedom Broker Upgrades Morgan Stanley (MS) to Buy